Back

Bayer AG

Ticker: BAYZF
Add to portfolio Portfolio analysis in 2min
Stock Large-cap Dividend payer Trading above 200-day average Near 52-week high
Market cap
$43.03B
Forward P/E
8.58
Profit margin
-4.77%
Revenue growth QoQ
-2.40%
Div. yield
0.25%
Beta
0.84
$56.13 2.05%
Price as of 2026-09-21 · OTCQX

Performance by timeframe

Rolling returns
1 Month -0.09%
6 Months +30.62%
1 Year +73.79%
5 Years +2.45% p.a.+12.86%
10 Years -2.68% p.a.-23.74%
Since inception +5.65% p.a.+294.41%
Calendar year returns
YTD +30.86%
2025 +119.51%
2024 -46.71%
2023 -25.00%
2022 +0.39%
2021 -6.40%

Key stats

Market cap
43.03B
Dividend yield
0.25%
Beta
0.84
52-week range
26.60 - 58.16
50-day MA
45.46
200-day MA
40.52
Section 1

Business overview

Company profile data from fundamentals.

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Sector Healthcare
Industry Drug Manufacturers - General
Country Germany
Exchange OTCQX
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -6.93%
ROA 3.64%
Profit margin -4.77%
Operating margin 26.32%
PEG ratio 4.62
Revenue/share TTM 46.05
Revenue TTM 45.24B
EBITDA 10.16B
Gross profit TTM 27.11B
Beta 0.84

Valuation

Trailing P/E 0.00
Forward P/E 8.58
P/B 1.27
P/S 0.95
EV/EBITDA 20.77
EV/Revenue 1.45
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 0.00
Quarterly earnings growth 1.13%
Revenue TTM 45.24B
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 0.25%
Dividend per share 0.1100
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Ownership & short interest

Short ratio 0.00

Details

Instrument metadata and source update timestamps.

Symbol BAYZF
Name Bayer AG
Asset type STOCK
Exchange OTCQX
Currency USD
Country USA
Code + exchange BAYZF.OTCQX
Last price date 2026-05-18
Fundamentals updated 2026-05-19

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.